EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inhibitory effects of Δ8-tetrahydrocannabinol on major hepatic cytochrome P450 enzymes and implications for drug disposition

Mengqi Zhao, Shelby Coates, Keti Bardhi, Philip Lazarus

Drug Metabolism and Disposition · 2025

DOI: 10.1016/j.dmd.2025.100122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2025. Verfasst von Mengqi Zhao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular Biosciences, Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buff…. Hauptthemen laut MEDLINE: Dronabinol, Cytochrome P-450 Enzyme System, Cytochrome P-450 Enzyme Inhibitors, Liver. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Institutes of Health, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The increased use of cannabis in many parts of the United States and other countries has led to a need for a more comprehensive understanding of cannabis constituents and their potential for drug-drug interactions. Δ8-Tetrahydrocannabinol (Δ8-THC) is a psychoactive cannabinoid that is found at low concentrations in cannabis but is growing in popularity, especially where the use of Δ9-THC is restricted. Although certain cannabinoids including cannabidiol (CBD) are known to inhibit several metabolizing enzymes including many in the cytochrome P450 family, the effects of Δ8-THC remain poorly characterized. This study evaluated the inhibitory potential of Δ8-THC and its metabolites, 11-hydroxy-Δ8-THC and 11-nor-Δ8-THC-9-carboxylic acid, on major hepatic cytochrome P450 enzymes using in vitro assays with recombinant P450-overexpressing microsomes and pooled human liver microsomes. Δ8-THC and 11-hydroxy-Δ8-THC significantly inhibited CYP2C9- and CYP3A4-mediated metabolism in a dose-dependent, reversible manner. Lineweaver-Burk analysis indicated competitive inhibition for CYP2C9-mediated warfarin hydroxylation and noncompetitive inhibition for CYP2C9- and CYP3A4-mediated metabolism of diclofenac and midazolam, respectively. In contrast, 11-nor-Δ8-THC-9-carboxylic acid showed no significant inhibition of P450 enzymes. Static modeling predicted clinically relevant drug interactions, particularly with oral Δ8-THC. These findings underscore the potential for Δ8-THC to impact the pharmacokinetics of coadministered drugs and highlight the need for further clinical studies. SIGNIFICANCE STATEMENT: This study is the first to assess how Δ8-tetrahydrocannabinol and its active metabolites inhibit key hepatic P450 enzymes. Results suggest a high risk of Δ8-tetrahydrocannabinol-related drug interactions, especially with oral use, underscoring the need for clinical caution and further research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DronabinolCytochrome P-450 Enzyme SystemCytochrome P-450 Enzyme InhibitorsLiverHumansMicrosomes, LiverDrug InteractionsCytochrome P-450 CYP2C9

Stichwörter der Autor:innen

CYP450CannabinoidCannabisDrug-drug interactionsTetrahydrocannabinol

Substanzen

DronabinolCytochrome P-450 Enzyme SystemCytochrome P-450 Enzyme InhibitorsCytochrome P-450 CYP2C9

Autor:innen und Institutionen

  • Division of Molecular Biosciences, Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, New York.
  • Department of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, Washington.
  • Division of Molecular Biosciences, Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, New York. Electronic address: plazarus@buffalo.edu.

Förderung

  • NCI NIH HHS
  • National Institutes of Health
  • National Cancer Institute
  • State of Washington

Zitieren

APA

Zhao, M., Coates, S., Bardhi, K., & Lazarus, P. (2025). Inhibitory effects of Δ8-tetrahydrocannabinol on major hepatic cytochrome P450 enzymes and implications for drug disposition. Drug Metabolism and Disposition. https://doi.org/10.1016/j.dmd.2025.100122

Vancouver

Zhao M, Coates S, Bardhi K, Lazarus P. Inhibitory effects of Δ8-tetrahydrocannabinol on major hepatic cytochrome P450 enzymes and implications for drug disposition. Drug Metabolism and Disposition. 2025. doi:10.1016/j.dmd.2025.100122

BibTeX
@article{Zhao2025,
  author = {Zhao, Mengqi and Coates, Shelby and Bardhi, Keti and Lazarus, Philip},
  title = {Inhibitory effects of Δ8-tetrahydrocannabinol on major hepatic cytochrome P450 enzymes and implications for drug disposition},
  journal = {Drug Metabolism and Disposition},
  year = {2025},
  doi = {10.1016/j.dmd.2025.100122}
}
Kostenlos starten →